Skip to main content
. Author manuscript; available in PMC: 2009 Oct 30.
Published in final edited form as: J Neurosurg. 2008 Oct;109(4):699–707. doi: 10.3171/JNS/2008/109/10/0699

Fig. 3.

Fig. 3

Graph showing the incidence of infections. No clinical safety concerns were observed in the cyclosporine-treated patients. The incidence of infectious complications did not differ between dosing groups or between cyclosporine-treated patients and placebo controls. UTI = urinary tract infection.